Basal progesterone level as the main determinant of progesterone elevation on the day of hCG triggering in controlled ovarian stimulation cycles

Arch Gynecol Obstet. 2014 Jul;290(1):169-76. doi: 10.1007/s00404-014-3167-y. Epub 2014 Feb 19.

Abstract

Purpose: Modest increases of serum progesterone at human chorionic gonadotrophin (hCG) administration in controlled ovarian hyperstimulation (COH) cycles have been shown to have a negative impact on pregnancy outcomes. The aim of this study was to identify early predictors of progesterone elevation at hCG.

Design: Pregnancy outcome of 303 consecutive patients undergoing COH and fresh day-3 embryo transfer was analysed. Considering the non-linear relationship between progesterone at hCG triggering and pregnancy outcomes, partial area under the curve (pAUC) analysis was used to implement marker identification potential of receiver operating characteristic (ROC) curve analysis. Multivariate logistic analysis was then performed to identify predictors of progesterone rise.

Results: Pregnancy outcomes could be predicted by pAUC analysis (pAUC = 0.58, 95 % CI 0.51-0.66, p = 0.02) and a significant detrimental cut-off could be calculated (progesterone at hCG > 1.35 ng/ml). Total dose of rFSH administered, E2 level at hCG but mostly basal progesterone level (OR = 12.21, 95 % CI 1.82-81.70) were predictors of progesterone rise above the cut-off.

Conclusion: Basal progesterone is shown to be the main prognostic factor for progesterone elevation. This observation should be taken into consideration in the clinical management of IVF/ICSI cycles to improve pregnancy outcomes.

Publication types

  • Observational Study

MeSH terms

  • Adult
  • Area Under Curve
  • Chorionic Gonadotropin / administration & dosage
  • Chorionic Gonadotropin / metabolism*
  • Embryo Transfer
  • Estradiol / blood
  • Female
  • Fertilization in Vitro*
  • Gonadotropin-Releasing Hormone / blood
  • Gonadotropin-Releasing Hormone / metabolism
  • Humans
  • Logistic Models
  • Menstrual Cycle
  • Ovarian Hyperstimulation Syndrome* / blood
  • Ovary / drug effects
  • Ovary / physiology*
  • Ovulation Induction / methods
  • Pregnancy
  • Pregnancy Outcome
  • Progesterone / blood*
  • ROC Curve
  • Retrospective Studies
  • Sperm Injections, Intracytoplasmic / methods*
  • Treatment Outcome

Substances

  • Chorionic Gonadotropin
  • Gonadotropin-Releasing Hormone
  • Progesterone
  • Estradiol